한글목차

백신용 세포배양 배지 시장은 2026년에 22억 1,760만 달러로 추정되며, 2033년까지 37억 2,740만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 연평균 성장률(CAGR)은 7.7%를 기록할 전망입니다.

세포배양 배지는 세포의 성장을 지원하고 세포주기를 조절하는 적절한 에너지원과 화합물로 구성되어 있습니다. 일반적인 배양 배지는 비타민, 무기염, 아미노산 보충제, 포도당, 그리고 성장인자, 호르몬, 접착인자의 공급원 역할을 하는 혈청으로 구성됩니다. 또한, 배지는 pH와 삼투압 유지에도 도움이 됩니다.

시장 역학

감염성 질환의 증가 추세는 세계 백신용 세포배양 배지 시장의 성장을 이끄는 주요 요인입니다. 미국 질병예방통제센터(CDC)에 따르면, 2017년 8월 미국에서는 약 104건의 검사실에서 확인된 독감 관련 소아 사망 사례가 보고되었습니다. 이 중 66건은 A형 독감 바이러스와 관련이 있고, 38건은 B형 독감 바이러스와 관련이 있습니다. 또한, 백신을 통한 질병 예방에 대한 국민들의 인식 개선을 위한 정부의 노력이 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 미국 질병예방통제센터(CDC)에 따르면 2015년 독감 백신 접종으로 약 190만 건의 독감 발병, 96만 6천 건의 독감 관련 진료, 약 6만 7천 건의 독감 관련 입원을 예방하여 미국 내 질병 부담을 6.5% 감소시켰다고 합니다. 감소하였습니다.

그러나 높은 오염 위험이 시장 성장의 걸림돌로 작용할 수 있습니다. 2014년 ResearchGate지 기사에 따르면, 태아 소 혈청(FBS)에는 내독소, 마이코플라스마, 바이러스 오염물질, 소해면상뇌증(BSE)을 유발할 수 있는 프리온 등의 인자가 포함되어 있는 것으로 알려져 있습니다.

본 조사의 주요 특징

• 이 보고서는 백신용 세포배양 배지 세계 시장에 대한 상세한 분석을 제공하며, 2017년을 기준 연도로 하여 예측 기간(2018-2026년)의 시장 규모와 CAGR%를 제시합니다.
• 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 시장 촉진요인, 억제요인, 기회, 영향 분석, Porter's 분석, PEST 분석, 규제 시나리오, 주요 개발, 원자재 분석, 공급망 분석에 대한 중요한 인사이트도 제공합니다.
• 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략, 미래 계획 등 다양한 매개 변수를 기반으로 세계 백신 세포배양 배지 시장의 주요 기업을 프로파일링합니다.
• 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내리는 데 도움이 될 것입니다.
• 이 세계 백신 세포배양 배지 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 백신용 세포배양 배지 세계 시장 분석에 사용된 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

제2장 시장 범위

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 백신용 세포배양 배지 시장 : 배지 유형별, 2026-2033년

제5장 세계의 백신용 세포배양 배지 시장 : 용도별, 2026-2033년

제6장 세계의 백신용 세포배양 배지 시장 : 지역별, 2026-2033년

제7장 경쟁 구도

제8장 섹션

영문목차

Cell Culture Media For Vaccine Market is estimated to be valued at USD 2,217.6 Mn in 2026 and is expected to reach USD 3,727.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).

Key features of the study

• This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter's analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
• It profiles key players in the global cell culture media for vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market

Market Segmentation

• By Media Type
  • Bovine Derived
  • Fetal bovine serum (FBS)
  • Newborn Calf Serum (NBCS)
  • Adult Bovine Serum (ABS)
  • Bovine Serum Albumin (BSA)
  • Bovine Calf Serum (BCS)
  • Porcine Derived
  • Animal free/Serum Free Cell Culture
• By Application
  • Human Vaccines
  • Animal Vaccines
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • HiMedia Laboratories
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • General Electric Company
  • Sartorius AG
  • Proliant, Inc.
  • Bovogen Biologicals Pty. Ltd.
  • Rocky Mountain Biologicals
  • Valley Biomedical
  • Moregate BioTech
  • Atlanta Biologicals
  • Creative-Biolabs
  • Life Technologies (India) Pvt Ltd.
  • Axil Scientific Pte Ltd.
  • Indian Immunologicals Limited
  • Serum Institute of India Pvt. Ltd.
  • Sisco Research Laboratories Pvt. Ltd.
  • Valneva SE

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Media Type
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Porter's analysis
• PEST analysis
• Regulatory Scenario
• Key Developments
• Raw material analysis
• Supply chain analysis

4. Global Cell Culture Media for Vaccine Market, By Media Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Bovine Derived
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Fetal bovine serum (FBS)
• Newborn Calf Serum (NBCS)
• Adult Bovine Serum (ABS)
• Bovine Serum Albumin (BSA)
• Bovine Calf Serum (BCS)
• Porcine Derived
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Animal free/Serum Free Cell Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Cell Culture Media for Vaccine Market, By Application, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Human Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Animal Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Cell Culture Media for Vaccine Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
• North America
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • HiMedia Laboratories
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Merck KGaA
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • General Electric Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Sartorius AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Proliant, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Bovogen Biologicals Pty. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Rocky Mountain Biologicals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Valley Biomedical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Moregate BioTech
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Atlanta Biologicals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Creative-Biolabs
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Life Technologies (India) Pvt Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Axil Scientific Pte Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Indian Immunologicals Limited
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Valneva SE
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

8. Section

• References
• Research Methodology
• About us and Sales Contact